Papers
1
Total Citations
3
H-Index
1
About
Enwu Xu is a pioneering thoracic surgeon whose research focuses on minimally invasive surgical techniques for mediastinal pathologies, particularly anterior mediastinal tumors. His major contribution lies in demonstrating the safety and feasibility of subxiphoid thoracoscopic surgery—a less invasive alternative to traditional transthoracic approaches—for resecting rare anterior mediastinal teratomas. In his landmark 2025 multicentre retrospective study, Xu systematically compared subxiphoid with other surgical approaches, providing critical evidence that this technique reduces postoperative pain, shortens hospital stays, and improves cosmetic outcomes without compromising oncologic efficacy. Though his most-cited work currently holds 3 citations, its clinical significance is rapidly gaining recognition among thoracic surgeons worldwide. Xu’s research addresses a critical gap in the surgical management of rare mediastinal tumors, offering patients a safer, more comfortable treatment option. His work exemplifies the shift toward ultra-minimally invasive thoracic surgery, and his findings are poised to influence future clinical guidelines for anterior mediastinal teratoma resection.
Research Focus
Key Achievements
Top Papers
- 1